NCT06640153

Brief Summary

Accurate preoperative Siewert classification, precise assessment of the extent of esophageal involvement, and staging is crucial for determining the appropriate surgical approach and achieving negative resection margins. The purpose of this study is to investigate the diagnostic performance of the Multi-parametric magnetic resonance imaging (mpMRI) and computed tomography (CT) in gastroesophageal junction and upper gastric cancers.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
16mo left

Started Aug 2024

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress57%
Aug 2024Aug 2027

Study Start

First participant enrolled

August 21, 2024

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

October 7, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

October 15, 2024

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 24, 2025

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 24, 2027

Expected
Last Updated

October 15, 2024

Status Verified

October 1, 2024

Enrollment Period

1 year

First QC Date

October 7, 2024

Last Update Submit

October 10, 2024

Conditions

Keywords

MRCTAdenocarcinoma of the Gastroesophageal JunctionGastric Cancer

Outcome Measures

Primary Outcomes (3)

  • Siewert classification

    Compare the findings of multiparametric MRI and CT in the Siewert classification (Types I, II, and III) against a histopathological reference standard, evaluating sensitivity, specificity, positive predictive value, and negative predictive value.

    2 years

  • length of esophageal involvement

    The accuracy and AUC of length of esophageal involvement (not involved, 0-2cm, 2-3cm, 3-4cm, \>4cm) evaluated by CT and MRI.

    2 years

  • Staging

    Compare the cancer stage (according to AJCC 8th edition TNM-classification) as determined by mpMRI compared to CT at primary staging and at restaging. The proportion of upgraded, downgraded, and right patients are determined.

    2 years

Secondary Outcomes (2)

  • Survival time and recurrence time

    3 years

  • The number of patients with complications

    Within 30 days after the day of operation

Study Arms (1)

Experimental: Gastroesophageal junction or upper gastric adenocarcinoma

Patients with biopsy verified gastroesophageal junction or upper gastric adenocarcinoma undergo mpMRI in addition to conventional CT imaging

Diagnostic Test: mpMRI

Interventions

mpMRIDIAGNOSTIC_TEST

Gastroesophageal junction or upper gastric adenocarcinoma patients undergo mpMRI at siewert classification, length of esophageal involvement, primary staging and restaging

Experimental: Gastroesophageal junction or upper gastric adenocarcinoma

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients diagnosed with gastroesophageal junction or upper gastric adenocarcinoma who are candidates for radical surgical intervention.

You may qualify if:

  • patients with gastric cancer confirmed by preoperative gastroscopic biopsy;
  • underwent standardized mpMRI and CT examination;
  • patients with complete postoperative pathological data and pathological results of gastroesophageal Junction or upper gastric adenocarcinoma;

You may not qualify if:

  • combined with other tumors;
  • Clinical and imaging data were missing or could not meet the research needs;
  • the location of lesions could not be determined;

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The First Affiliated Hospital with Nanjing Medical University

Nanjing, Jiangsu, China

Location

MeSH Terms

Conditions

Stomach Neoplasms

Interventions

Multiparametric Magnetic Resonance Imaging

Condition Hierarchy (Ancestors)

Gastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesStomach Diseases

Intervention Hierarchy (Ancestors)

Magnetic Resonance ImagingTomographyDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 7, 2024

First Posted

October 15, 2024

Study Start

August 21, 2024

Primary Completion

August 24, 2025

Study Completion (Estimated)

August 24, 2027

Last Updated

October 15, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

Locations